DNMT3A and non-small cell lung carcinoma: Yu et al. revealed that miR-26a-5p targeted DNMT3A to reduce the degree of global methylation in non-small cell lung cancer and restore the SFRP1 expression, thereby regulating cell viability and the stem-like phenotype by regulating the Wnt/β-catenin pathway [33].